Abstract
Clays play an important role in health products as it has been used as excipients for solid dosage forms and as active ingredients. Usually, excipients are pharmacologically inert, but they can interact with drugs in the solid dosage form and affect their bioavailability. Thus, the aim of this work was to determinate the physicochemical properties of palygorskite clay from Piauí, Brazil, and to investigate the potential use of this mineral as excipient for solid dosage forms containing rifampicin and isoniazid, which are drugs currently used to treat tuberculosis. Palygorskite was analyzed by X-ray fluorescence, X-ray diffraction, transmission electron microscopy, and particle size analyzer. According to the results, the main component found was SiO2, and its mineral composition contains palygorskite, dolomite, and quartz. The particles appear as fibers with bundle-like aspect that cluster together to form aggregates. The results from thermal analysis indicate that there is no interaction between both rifampicin and isoniazid with palygorskite. Moreover, the presence of palygorskite did not interfere on the dissolution of these drugs, which suggests that this material can be potentially used as an excipient for these drugs.
Similar content being viewed by others
References
Dutra RPS, Varela ML, Gomes UU, Nascimento do RM, Paskocimas CA, Melo PT. Avaliação da Potencialidade de Argilas do Rio Grande do Norte-Brasil. Cerâm Industr. 2006;36(2):42–6.
Viseras C, Lopez-Galindo A. Pharmaceutical applications of some spanish clays (sepiolite, palygorskite, bentonite): some preformulations studies. Appl Clay Sci. 1999;14:69–82.
Iborra CV, Cultrone G, Cerezo P, Aguzzi C, Baschini MT, Vllés J, Lopez-Galindo A. Characterisation of northern patagonian bentonites for pharmaceutical uses. Appl Clay Sci. 2006;32:272–81.
Carretero MI, Pozo M. Clay and non-clay minerals in the pharmaceutical industry, part I: excipients and medical applications. Appl Clay Sci. 2009;46:73–80.
Carretero MI, Pozo M. Clay and non-clay minerals in the pharmaceutical and cosmetical industries, part II: active ingredients. Appl Clay Sci. 2010;47:171–81.
Jung H, Kim H, Choy YB, Hwang SJ, Choy JH. Laponite-based nanohybrid for enhanced solubility and controlled release of itraconazole. Int J Pharm. 2008;349:283–90.
Park JK, Choy YB, Oh JM, Kima JY, Hwanga SJ, Choy JH. Controlled release of donepezil intercalated in smectite clays. Int J Pharm. 2008;359:198–204.
Joshi GV, Kevadiya BD, Patel HA, Bajaj HC, Jasra RV. Montmorillonite as a drug delivery system: intercalation and in vitro release of timolol maleate. Int J Pharm. 2009;374:53–7.
Cornejo J, Hermosin MC, White JL, Peck GE, Hhem SL. Role of ferric iron in the oxidation of hydrocortisone by sepiolite and palygorskite. Clays Clay Miner. 1983;31(2):109–12.
White JL, Hem SL. Pharmaceutical aspects for clay–organic interactions. Ind Eng Chem Prod Res Dev. 1983;22:665–71.
Naggar VF. An in vitro study of the interaction between diazepam and some antacids or excipients. Pharmazie. 1981;36:114–7.
Dhanaraju MD, Kumaran KS, Baskaran T, Moorthy MS. Enhancement of bioavailability of griseofulvin by its complexation with beta-cyclodextrin. Drug Dev Ind Pharm. 1998;24(6):583–7.
Panakanti R, Narang AS. Impact of excipient interactions on drug bioavailability from solid dosage forms. Pharm Res. 2012. doi:10.1007/s11095-012-0767-8.
Santos AFO, Basilio ID, de Souza FS, Medeiros AFD, Pinto MF, de Santana DP, et al. Application of thermal analysis in study of binary mixtures with metformin. J Therm Anal Calorim. 2008;93:361–4.
Freire F, Aragão CF, Moura TFAL, Raffin FN. Compatibility study between chlorpropamide and excipients in their physical mixtures. J Therm Anal Calorim. 2009;97:355–7.
Lavor EP, Freire F, Aragão CF, Moura TFAL, Raffin FN. Application of thermal analysis to the study of anti-tuberculosis drug compatibility: part I. J Therm Anal Calorim. 2011. doi:10.1007/10973-01101770-8.
Pinto MA, de Moura EA, de Souza FS, Macêdo RO. Thermal compatibility studies of nitroimidazoles and excipients. J Therm Anal Calorim. 2010;102:323–9.
Frost RL, Ding Z. Controlled rate thermal analysis and differential scanning calorimetry of sepiolites and palygorskites. Thermochim Acta. 2003;397:119–28.
World Health Organization. Global tuberculosis control: WHO report 2011. Available at: http://www.who.int/tb/publications/global_report/2011/gtbr11_full.pdf Accessed 03 July 2012.
Amidon GL, Lennernäs H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res. 1995;12:413–20.
Shishoo CJ, Shah SA, Rathod IS, Savale SS, Vora MJ. Impaired bioavailability of rifampicin in presence of isoniazid from fixed dose combination (FDC) formulation. Int J Pharm. 2001;228:53–67.
Pelizza G, Nebuloni M, Ferrari P, Gallo GG. Polymorphism of rifampicin. Farmaco Sci. 1977;32:471–81.
Henwood SQ, de Villiers MM, Leibenberg W, Lotter AP. Solubility and dissolution properties of generic rifampicin raw materials. Drug Dev Ind Pharm. 2000;26:403–8.
Singh S, Mariappan TT, Sankar R, Sarda N, Singh B. A critical review of the probable reasons for the poor/variable bioavailability of rifampicin from anti-tubercular fixed-dose combination (FDC) products, and the likely solutions to the problem. Int J Pharm. 2001;228:5–17.
Agrawal S, Ashokraj Y, Bharatam PV, Pillai O, Panchagnula R. Solid state characterization of rifampicin samples and its biopharmaceutic relevance. Eur J Pharm Sci. 2004;22:127–44.
Liu H, Chen T, Chang D, Chen D, Qing C, Xie J, Frost RL. The difference of thermal stability between Fe-substituted palygorskite and Al-rich palygorskite. J Therm Anal Calorim. 2012. doi:10.1007/s10973-012-2363-x.
Cheng H, Yang J, Frost RL. Thermogravimetric analysis–mass spectrometry (TG–MS) of selected Chinese palygorskites: implications for structural water. Thermochim Acta. 2011;512:202–7.
Freire F, Aragão CF, Moura TFAL, Raffin FN. Thermal studies of isoniazid and mixtures with rifampicin. J Therm Anal Calorim. 2009;97:333–6.
Akyuz S, Akyuz T, Akalin E. Adsorption of isoniazid onto sepiolite–palygorskite group of clays: an IR study. Spectrochim Acta Part A. 2010;75:1304–7.
Lavor EP, Freire FD, Aragão CF, Raffin FN, Moura TFAL. Application of thermal analysis to the study of anti-tuberculosis drug-excipient compatibility Part 1. J Therm Anal Calorim. 2012;108:207–12.
Wang J, Wen H, Desai D. Lubrication in tablet formulations. Eur J Pharm Biopharm. 2010;75:1–15.
McGinity JW, Harris MR. Increasing dissolution rates of poorly soluble drugs by adsorption to montmorillonite. Drug Dev Ind Pharm. 1980;6:35–48.
Sanganwar GP, Gupta RB. Dissolution-rate enhancement of fenofibrate by adsorption onto silica using supercritical carbon dioxide. Int J Pharm. 2008;360(1–2):213–8.
Acknowledgements
The authors wish to thank NUPLAM/UFRN for the supply the samples and FAPERN and CNPq for financial support for this project.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
dos Santos Soares, D., Fernandes, C.S., da Costa, A.C.S. et al. Characterization of palygorskite clay from Piauí, Brazil and its potential use as excipient for solid dosage forms containing anti-tuberculosis drugs. J Therm Anal Calorim 113, 551–558 (2013). https://doi.org/10.1007/s10973-013-3291-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10973-013-3291-0